BioRestorative Therapies BRTX
NASDAQ BRTX
$1.57 +0.04 (+2.61%)
At close: Nov 11, 2026 · 4:00 PM EST

BioRestorative Therapies (BRTX) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

BioRestorative Therapies' Return on Capital Employed [ROCE] came in at -518.17% for Q1 2026, down 346.10 percentage points from -172.07% a year earlier but up 856.49 percentage points from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, BioRestorative Therapies' Return on Capital Employed [ROCE] was -351.08%, down 218.22 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -203.27 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -132.86% in FY2024 (-5.12 pp), -127.74% in FY2023 (+13.21 pp), -140.94% in FY2022 (+60.86 pp) and -201.80% in FY2021 (-53.99 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -1397.74% (Q3 2021) to -110.14% (Q2 2024).
  • Year-over-year, Return on Capital Employed [ROCE] has declined for five consecutive quarters, with an average year-over-year change of -189.92 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2021 (a gain of 1363.25 percentage points), and the weakest in Q4 2025 (a drop of 1255.26 percentage points).
  • Business Quant data shows BRTX's Return on Capital Employed [ROCE] at -1374.66% (Q4 2025), -398.25% (Q3 2025) and -227.63% (Q2 2025) in the three quarters before Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 BioRestorative Therapies 1.36 Mn -17.06 Mn 15,785.00 -518.17%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -518.17%
Dec 31, 2025 -1,374.66%
Sep 30, 2025 -398.25%
Jun 30, 2025 -227.63%
Mar 31, 2025 -172.07%
Dec 31, 2024 -119.39%
Sep 30, 2024 -112.27%
Jun 30, 2024 -110.14%
Mar 31, 2024 -114.51%
Dec 31, 2023 -143.60%
Sep 30, 2023 -158.08%
Jun 30, 2023 -583.14%
Mar 31, 2023 -253.94%
Dec 31, 2022 -169.48%
Sep 30, 2022 -170.36%
Jun 30, 2022 -132.39%
Mar 31, 2022 -233.39%
Dec 31, 2021 -220.14%
Sep 30, 2021 -1,397.74%
Jun 30, 2021 -1,020.77%
API Access

BioRestorative Therapies Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BRTX&period=max&api_key=YOUR_API_KEY